SCHEMBL12014657

SCHEMBL12014657

c1ccc(-c2nc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)nc(-c3cc4c5ccccc5ccc4c4ccccc34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
HPRT1 P00492 4/20 0.41
SOS1 Q07889 1/20 0.40
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
ALDH1A1 P00352 6/20 0.39
HPGD P15428 4/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 2/20 0.39
HIF1A Q16665 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12014607 0.93 MAPT (0.42) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL19271418 0.91 HPRT1 (0.50) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL12014510 0.90 MAPT (0.42) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL17995351 0.89 HPRT1 (0.48) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL12014511 0.88 MAPT (0.39) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL12655934 0.88 SOS1 (0.41) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL12014504 0.87 HSD17B10 (0.42) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL26031573 0.86 TSHR (0.46) MAPTLMNASMN1; SMN2NPC1RECQL
SCHEMBL20624260 0.85 ESR1 (0.38) MAPTLMNASMN1; SMN2ESR1ESR2
SCHEMBL12014609 0.85 MAPT (0.38) MAPTLMNASMN1; SMN2NPC1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120217449-A1 MATERIALS FOR ELECTRONIC DEVICES EFNA1, DDT, ERCC1 MAPT 1295/4885LMNA 2254/4885SMN1; SMN2 3045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.